Radiobiological aspects of high altitude flight : relative biological effectiveness of fast neutrons in suppressing immune capacity to an infective agent.
Friedberg, W., Neas, B. R., Faulkner, D. N., Hannenman, G. D., & Darden, E. (1978). Radiobiological aspects of high altitude flight : relative biological effectiveness of fast neutrons in suppressing immune capacity to an infective agent (Report No. FAA-AM-78-8). Civil Aerospace Medical Institute. https://rosap.ntl.bts.gov/view/dot/21118
Friedberg, Wallace, Barbara R. Neas, Donald N. Faulkner, Gerald D. Hannenman, and E.B. Darden. Radiobiological aspects of high altitude flight : relative biological effectiveness of fast neutrons in suppressing immune capacity to an infective agent. Report no. FAA-AM-78-8. Civil Aerospace Medical Institute, 1978. https://rosap.ntl.bts.gov/view/dot/21118.
Friedberg, Wallace, et al. Radiobiological aspects of high altitude flight : relative biological effectiveness of fast neutrons in suppressing immune capacity to an infective agent. Civil Aerospace Medical Institute, 1978, Report no. FAA-AM-78-8, ROSA P. https://rosap.ntl.bts.gov/view/dot/21118.
We investigated the relative biological effectiveness (RBE) of fast neutrons compared with X-rays in impeding development of immunity to an infective agent, the intestinal cestode Hymenolepis nana. Mice were irradiated with neutrons or X-rays and 2 days later given an immunizing dose of H. nana eggs. After another 2 days, the mice received a challenge dose of the eggs. Challenge egg doses were also given to sham-irradiated unimmunized and immunized controls.
;
All mice were killed 90 to 92 hours after challenge, and the H. nana larvae (cysticercoids) that developed in the intestinal tissue were counted. An increased cysticercoid count in the irradiated mice, as compared with the count in unirradiated immunized controls, reflects suppression of immune capacity by the radiation. The results indicate a neutron RBE of 4 at 50 and 101 rad.
Friedberg, W., Neas, B. R., Faulkner, D. N., Hannenman, G. D., & Darden, E. (1978). Radiobiological aspects of high altitude flight : relative biological effectiveness of fast neutrons in suppressing immune capacity to an infective agent (Report No. FAA-AM-78-8). Civil Aerospace Medical Institute. https://rosap.ntl.bts.gov/view/dot/21118
Friedberg, Wallace, Barbara R. Neas, Donald N. Faulkner, Gerald D. Hannenman, and E.B. Darden. Radiobiological aspects of high altitude flight : relative biological effectiveness of fast neutrons in suppressing immune capacity to an infective agent. Report no. FAA-AM-78-8. Civil Aerospace Medical Institute, 1978. https://rosap.ntl.bts.gov/view/dot/21118.
Friedberg, Wallace, et al. Radiobiological aspects of high altitude flight : relative biological effectiveness of fast neutrons in suppressing immune capacity to an infective agent. Civil Aerospace Medical Institute, 1978, Report no. FAA-AM-78-8, ROSA P. https://rosap.ntl.bts.gov/view/dot/21118.
ROSA P serves as an archival repository of USDOT-published products including scientific
findings, journal articles, guidelines, recommendations, or other information authored or co-authored by
USDOT or funded partners. As a repository, ROSA P retains documents in their original published format to
ensure public access to scientific information.
Links with this icon indicate that you are leaving a Bureau of Transportation
Statistics (BTS)/National Transportation Library (NTL)
Web-based service.
Thank you for visiting.
You are about to access a non-government link outside of
the U.S. Department of Transportation's National
Transportation Library.
Please note: While links to Web sites outside of DOT are
offered for your convenience, when you exit DOT Web sites,
Federal privacy policy and Section 508 of the Rehabilitation
Act (accessibility requirements) no longer apply. In
addition, DOT does not attest to the accuracy, relevance,
timeliness or completeness of information provided by linked
sites. Linking to a Web site does not constitute an
endorsement by DOT of the sponsors of the site or the
products presented on the site. For more information, please
view DOT's Web site linking policy.
To get back to the page you were previously viewing, click
your Cancel button.